Core Alternative Capital Portfolio Holdings

Core Alternative Capital

  • $448 Million
  • Q4 2024

Core Alternative Capital has filed its 13F form on January 29, 2025 for Q4 2024 where it was disclosed a total value porftolio of $448 Million distributed in 360 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $29.6M, Microsoft Corp with a value of $26.4M, Jpmorgan Chase & CO with a value of $18.1M, Alphabet Inc. with a value of $16.7M, and Eli Lilly & CO with a value of $12.5M.

Examining the 13F form we can see an decrease of $49.1M in the current position value, from $498M to 448M.

Below you can find more details about Core Alternative Capital portfolio as well as his latest detailed transactions.

Portfolio value $448 Million
Technology: $108 Million
Financial Services: $79.3 Million
Healthcare: $49 Million
Industrials: $46.8 Million
Consumer Defensive: $34.6 Million
Consumer Cyclical: $31.7 Million
Communication Services: $30.6 Million
Energy: $19.8 Million
Other: $48.4 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$44.2B
$1,000 0.0% of portfolio
5
Q4 2024 Added 25.0%
$71B
$1,000 0.0% of portfolio
14
Q1 2024 Reduced 92.05%
$28.4B
$0 0.0% of portfolio
1
Q3 2024 Reduced 97.5%
$45.2B
$3,000 0.0% of portfolio
65
Q1 2024 Reduced 78.04%
$32.2B
$1,000 0.0% of portfolio
16
Q1 2024 Reduced 89.47%
$38.7B
$1,000 0.0% of portfolio
18
Q1 2024 Reduced 90.53%
$46.9B
$10,000 0.0% of portfolio
42
Q1 2024 Reduced 16.0%
$72.8B
$2,000 0.0% of portfolio
46
Q1 2024 Reduced 90.32%
$45.1B
$1,000 0.0% of portfolio
14
Q1 2024 Reduced 90.67%
$12.8B
$0 0.0% of portfolio
7
Q1 2024 Reduced 93.46%
$37.2B
$1,000 0.0% of portfolio
28
Q1 2024 Reduced 87.04%
$9.36B
$2,000 0.0% of portfolio
22
Q1 2024 Reduced 90.27%
$23.7B
$1,000 0.0% of portfolio
5
Q1 2024 Reduced 87.5%
Morgan Stanley Glbl Franchise Class I
-
$0 0.0% of portfolio
-
Q2 2024 New
$72.6B
$4,000 0.0% of portfolio
15
Q1 2024 Reduced 80.26%
Ge Vernova Inc Com
-
$0 0.0% of portfolio
-
Q2 2024 New
$31.9B
$0 0.0% of portfolio
1
Q1 2024 Reduced 98.51%
$35.5B
$0 0.0% of portfolio
15
Q4 2024 Added 25.0%
$77.3B
$10,000 0.0% of portfolio
36
Q1 2024 Reduced 63.64%
$66.8B
$4,000 0.0% of portfolio
79
Q1 2024 Reduced 87.4%
$68.8B
$17,000 0.0% of portfolio
98
Q4 2024 Reduced 49.48%
$10.5B
$0 0.0% of portfolio
13
Q1 2024 Reduced 87.38%
$45.2B
$1,000 0.0% of portfolio
2
Q1 2024 Reduced 90.91%
$16.6B
$0 0.0% of portfolio
8
Q1 2024 Reduced 91.11%
$64B
$11,000 0.0% of portfolio
139
Q4 2024 Added 256.41%
$17.3B
$0 0.0% of portfolio
12
Q1 2024 Reduced 93.75%
$85.3B
$4,000 0.0% of portfolio
10
Q1 2024 Reduced 87.18%
$30.8B
$2,000 0.0% of portfolio
52
Q1 2024 Reduced 79.84%
Ge Healthcare Technologies Inc Common Stock
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 24.62%
$12.2B
$1,000 0.0% of portfolio
27
Q1 2024 Reduced 88.21%
$11.1B
$0 0.0% of portfolio
5
Q1 2024 Reduced 96.0%
$19.4B
$1,000 0.0% of portfolio
12
Q1 2024 Reduced 82.86%
$94.5B
$6,000 0.0% of portfolio
82
Q1 2024 Reduced 84.05%
$26.7B
$2,000 0.0% of portfolio
46
Q1 2024 Reduced 73.86%
$65.3B
$2,000 0.0% of portfolio
10
Q1 2024 Reduced 94.44%
$140B
$6,000 0.0% of portfolio
65
Q1 2024 Reduced 89.67%
$27.1B
$0 0.0% of portfolio
5
Q1 2024 Reduced 94.57%
$35B
$1,000 0.0% of portfolio
3
Q1 2024 Reduced 86.96%
$69.8B
$4,000 0.0% of portfolio
15
Q4 2024 Added 7.14%
$12.5B
$0 0.0% of portfolio
4
Q1 2024 Reduced 93.65%
$32.7B
$0 0.0% of portfolio
4
Q1 2024 Reduced 93.65%
$13.5B
$1,000 0.0% of portfolio
21
Q1 2024 Reduced 87.35%
$0
$18,000 0.0% of portfolio
440
Q1 2024 New
$175B
$17,000 0.0% of portfolio
33
Q4 2024 Added 43.48%
$173B
$10,000 0.0% of portfolio
17
Q1 2024 Reduced 85.95%
$93.2B
$4,000 0.0% of portfolio
235
Q3 2024 Reduced 89.49%
$19.8B
$0 0.0% of portfolio
8
Q1 2024 Reduced 91.11%
$33.5B
$1,000 0.0% of portfolio
4
Q4 2024 Added 100.0%
$100B
$6,000 0.0% of portfolio
23
Q1 2024 Reduced 86.55%

Summary

  • Portfolio
  • No. of Stocks 360
  • Current Value $448 Million
  • Prior Value $498 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 29, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 13 stocks
  • Additional Purchases 52 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 87 stocks
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email